Abstract
Pharmaceutical companies contribute over $13,000 per physician for promotion and advertisement of products. Psychiatrists and psychiatric residents are influenced by these interactions. Two recommendations to psychiatric residency training programs are offered: Incorporation of ethics education into teaching forums and the establishment of specific ground rules that would govern the interaction of pharmaceutical companies with psychiatric residents.Preview Only. This article cannot be rented because we do not currently have permission from the publisher.
Preview Only
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy